Preferred Name

Brivaracetam

Synonyms
Definitions

An orally bioavailable levetiracetam derivative, with anticonvulsant activity. Although the exact mechanism through which brivaracetam exerts its effects is not fully known, this agent targets and binds to synaptic vesicle protein 2A (SV2A) in the brain. This prevents synaptic vesicle exocytosis and the synaptic release of certain, as of yet not fully known, excitatory neurotransmitters. This may inhibit impulse conduction across synapses, decrease neuronal (hyper-)excitability, and may modulate epileptogenesis. SV2A, a membrane glycoprotein present in neuronal synaptic vesicles, plays a key role in action potential-induced neurotransmitter release in the brain.

ID

http://purl.obolibrary.org/obo/NCIT_C65270

CAS_Registry

357336-20-0

Chemical_Formula

C11H20N2O2

code

C65270

Contributing_Source

CTRP

FDA

definition

An orally bioavailable levetiracetam derivative, with anticonvulsant activity. Although the exact mechanism through which brivaracetam exerts its effects is not fully known, this agent targets and binds to synaptic vesicle protein 2A (SV2A) in the brain. This prevents synaptic vesicle exocytosis and the synaptic release of certain, as of yet not fully known, excitatory neurotransmitters. This may inhibit impulse conduction across synapses, decrease neuronal (hyper-)excitability, and may modulate epileptogenesis. SV2A, a membrane glycoprotein present in neuronal synaptic vesicles, plays a key role in action potential-induced neurotransmitter release in the brain.

Display_Name

Brivaracetam

FDA_UNII_Code

U863JGG2IA

in_subset

http://purl.obolibrary.org/obo/NCIT_C63923

http://purl.obolibrary.org/obo/NCIT_C176424

http://purl.obolibrary.org/obo/NCIT_C116977

http://purl.obolibrary.org/obo/NCIT_C116978

label

Brivaracetam

Legacy Concept Name

Brivaracetam

NCI_Drug_Dictionary_ID

792577

PDQ_Closed_Trial_Search_ID

792577

PDQ_Open_Trial_Search_ID

792577

Preferred_Name

Brivaracetam

prefixIRI

NCIT:C65270

prefLabel

Brivaracetam

Semantic_Type

Pharmacologic Substance

UMLS_CUI

C1699861

subClassOf

http://purl.obolibrary.org/obo/NCIT_C1509

http://purl.obolibrary.org/obo/NCIT_C264

Delete Subject Author Type Created
No notes to display